Press Release

CD BIOPARTICLES INTRODUCES REVERSED PHASE CHROMATOGRAPHY RESINS FOR BIOLOGICAL ANALYSIS



CD Bioparticles has launched a range of reversed-phase chromatography resins with different monodisperse particle sizes.

FOR IMMEDIATE RELEASE

29/03/2023

With years of experience in the pharmaceutical and life science sector, CD Bioparticles has launched a range of reversed-phase chromatography resins with different monodisperse particle sizes. CD Bioparticles adopts the world's leading patented technology and specially designs reversed-phase packing materials, applicable in the analysis and industrial separation of organic compounds, natural products, proteins, peptides, nucleic acids, etc.

Polymer reversed-phase resins have significant advantages in alkali resistance, longer product life and the ability to avoid tailing of basic compounds, so they complement reversed-phase silica gel chromatography in terms of separation performance and solvent compatibility. CD Bioparticles is an industry leader in the large-scale production of reversed-phase resins based on monodisperse porous spherical silica using advanced surface bonding and end-capping technology.

These reversed-phase chromatography resins contain C4, C8, C18, phenyl, and other functional groups according to the different surface modification forms. Depending on the matrix and properties, CD Bioparticles offers different types of reversed-phase resins, such as PS/DVB, PMMA, and PS/PMMA, to meet the requirements of reversed-phase chromatography analysis, and preparative separation and purification. In addition, CD Bioparticles can also provide customized products for special applications.

For example, the DiagNano™ Ester Porous PMMA Particles, 40 µm (Cat# PPA-01), are monodisperse, porous PMMA microparticles used for reversed-phase chromatography with high loading capacity. These microparticles with ester as terminal groups are stable in pH 1-14. Meanwhile, 500 Å pore size or other pore sizes are available upon request.

Another example is the DiagNano™ Phenyl Porous PS/DVB Particles, 40 µm (Cat# PPD-07), which are monodisperse, porous polystyrene/divinyl benzene microparticles used for reversed-phase chromatography with strong mechanical strength, high pressure resistant and high loading capacity. These microparticles contain hydrophobic surfaces with phenyl terminal groups. These porous PS/DVB particles are available with pore sizes of 300 Å, 500 Å, and 1000 Å, and other pore sizes are also supported upon request, stable in pH 1-14.

Reversed-phase chromatography resins from CD Bioparticles are suitable for a variety of fields, including laboratory analysis and biopharmaceutical, chemical medicine, and food and beverage. Researchers can utilize these resins for the analysis of breviscapine, teicoplanin, dalbavancin, vancomycin, polymyxin B, etc., as well as the analysis and separation of small molecule drugs, amino acids, PTC-amino acids, vitamins, polypeptides, etc.

CD Bioparticles also offers the world's largest selection of monodisperse polymeric chromatography packing materials, from sub-micron UPLC packing and HPLC packing to medium and low-pressure FPLC packing. These materials have been widely used in laboratory analysis, biopharmaceuticals, traditional Chinese medicine, chemical medicine, and other fields.

For more information about reversed-phase chromatography resins or to discuss your projects, please visit CD Bioparticles at https://www.cd-bioparticles.com.

About CD Bioparticles

CD Bioparticles is a leading manufacturer and supplier of various nanoparticles, microparticles, and coatings for R&D as well as commercialization across different application areas, including in vitro diagnostics, biochemistry, cellular analysis, cell separation, and immunoassay. The company also offers various custom services, including chemical surface-functionalization, fluorescent modification, antibody immobilization, as well as nucleic acid and oligo conjugation to meet client specifications.

Tags:
chromatography resins  |    |  

---

Organisation Profile:
CD Bioparticles is an established drug delivery company which provides customized solutions for developing and producing new, biocompatible drug delivery systems.






Press release contact details for CD Bioparticles

NameCD Bioparticles
Tel1-631-346-0027
Fax
Email
Websitehttps://www.cd-bioparticles.net/
OrganisationCD Bioparticles
Address
Town
County0
Postcode




Other press releases from CD Bioparticles

CD Bioparticles Launches Gene Silencing for Bio-research Application
CD Bioparticles Launches Gel Permeation Chromatography Resins
CD Bioparticles Introduces Reversed Phase Chromatography Resins for Biological Analysis
CD Bioparticles Launches mRNA Transfection Reagents for Research Applications
CD Bioparticles Launches Normal Phase Chromatography Resins for Chromatographic Analysis
CD Bioparticles Launches 3D Transfection Reagents for Bio-research Applications
CD Bioparticles Launches Affinity Chromatography Resins for Laboratory Usage
CD Bioparticles Announces Carrageenans for Scientific Applications
CD Bioparticles Launches New Chromatography Resins for Improved Analysis and Preparation of Chiral Compounds
CD Bioparticles Launches New Alginic Acids for Research Applications
CD Bioparticles Launches Locust Bean Gum for Biopharmaceutical Applications
CD Bioparticles Announces New PLGA-Based Drug Delivery Systems for In Vitro and In Vivo Applications
CD Bioparticles Launches New Line of Bioinks for 3D Bioprinting
CD Bioparticles Launches New Quantum Dots Labeling & Conjugation Kits
CD Bioparticles Introduces New Extraction and Purification Kits for Rapid and Reliable DNA Isolation
CD Bioparticles Launches New Tissue Engineering Scaffolds for Researchers
CD Bioparticles Launches New Line of Polystyrene Particles Conjugated with Biomolecules
CD Bioparticles Launches 3D Cell Culture Substrate for Bio-research
CD Bioparticles Announces the Launch of New Flow Cytometry Particles
CD Bioparticles Introduces the Launch of Engineered Tissue Scaffolds
CD Bioparticles Announces Polyamino Acids for Drug Delivery Applications
CD Bioparticles Launches New Line of Functional Polystyrene Particles
CD Bioparticles Announces Expanded Offerings of Polydimethylsiloxane for Cutting-Edge Research
CD Bioparticles Unveils Versatile Plain Polystyrene Particles for Diverse Bioresearch Applications
CD Bioparticles Launches New Range of Low PDI Polymers for Drug Delivery Applications
CD Bioparticles Launches New Line of Particles for Solid Phase Organic Synthesis
CD Bioparticles Introduces Innovative Agarose Particles for Purification of Proteins and Antibodies
CD Bioparticles Announces New Line of Polyacrylamides for Drug Delivery Studies
CD Bioparticles Announces Versatile Basic Agarose Particles for Efficient Biomolecule Separation
CD Bioparticles Introduces New Polyolefin Family Polymers for Drug Delivery Applications
CD Bioparticles Announces New Line of Conjugated Agarose Particles for Affinity Separation and Purification
CD Bioparticles Announces Offering of Polystyrene Family Polymers for Drug Delivery
CD Bioparticles Announces Comprehensive Assay Portfolio for mRNA-LNP Vaccine Development
CD Bioparticles Introduces Functional Agarose Particles for Biomedical Research Applications
CD Bioparticles Announces Advanced Capabilities in Customized Liposomes for Targeted Delivery
CD Bioparticles Simplifies Multi-Analyte Detection with Advanced Multiplex Particles
Endotoxin Free Gold Nanoparticles for Biomedical Research and Bioassay Development
CD Bioparticles Introduces Innovative Agonist-Based Adjuvants for Enhanced Vaccine Efficacy

Disclaimer:
Issuers of the press releases are solely responsible for the content of their press releases. Connect2business.co.uk cannot be held liable for the content posted by others to this website.